UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                   WASHINGTON, D.C. 20549
                              
                          FORM 8-K
                              
                       CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934

                        APRIL 7, 1999
                       ---------------
              (Date of earliest event reported)


         LABORATORY CORPORATION OF AMERICA HOLDINGS
         ------------------------------------------
   (Exact name of registrant as specified in its charter)


   DELAWARE              1-11353             13-3757370
   --------              -------             ----------
(State or other         (Commission         (IRS Employer
jurisdiction of         File Number)         Identification
incorporation)                               Number)


   358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
   -------------------------------------------------------
          (Address of principal executive offices)
                              
                        336-229-1127
                        ------------
    (Registrant's telephone number, including area code)
                              

ITEM 5. OTHER EVENTS On April 7, 1999, the Company issued a press release announcing that it reached an agreement with Universal Standard Healthcare Of Michigan, Inc. (Universal), for the Company to continue providing laboratory services for Universal and its customers, and an earlier notice of termination of services by the Company was rescinded, effective April 7, 1999. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS (c) Exhibit 20 Press release of the Company dated April 7, 1999.

SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS ------------------------------------------ (Registrant) By:/s/:BRADFORD T. SMITH ------------------------------ Bradford T. Smith Executive Vice President, General Counsel, Secretary and Compliance Officer Date: May 7, 1999

Laboratory Corporation of America-Registered Trademark-Holdings
358 South Main Street
Burlington, NC   27215

FOR IMMEDIATE RELEASE
- ---------------------                              
CONTACT:  336-584-5171                 SHAREHOLDER DIRECT: 800-LAB-0401
- -------                                ------------------  
Media - Cynthia Jay, Ext. 5052                             www.labcorp.com
Investors - Pamela Sherry, Ext. 4855
                              
                              
 LABCORP-REGISTERED TRADEMARK-AGREES TO RESCIND TERMINATION
 OF SERVICE AGREEMENT WITH UNIVERSAL STANDARD HEALTHCARE OF
                       MICHIGAN, INC.
                              
Burlington, NC --April 7, 1999 -- Laboratory Corporation of
America-Registered Trademark- Holdings (LabCorp-Registered
Trademark-) (NYSE: LH), headquartered in Burlington, North
Carolina, and Universal Standard Healthcare of Michigan,
Inc. (Universal), reached an agreement for LabCorp to
continue providing laboratory services  for Universal and
its customers, and an earlier notice of termination of
services by LabCorp was rescinded, effective April 7.
LabCorp and Universal engaged in extensive discussions after
LabCorp gave notice on March 30, 1999 to Universal of
termination of a laboratory services agreement between the
parties, and subsequently reached agreement for continued
service.
     "We are satisfied with the results of the agreement and
that no interruption of patient care occurred during these
discussions," said Stevan R. Stark, executive vice president
of sales and marketing for LabCorp.
     Laboratory Corporation of America-Registered Trademark-
Holdings (LabCorp-Registered Trademark-) is a national
clinical laboratory with annual revenues of $1.6 billion in
1998.  With 18,000 employees and over 100,000 clients
nationwide, the company offers more than 2,000 clinical
tests, ranging from simple blood analyses to more
sophisticated technologies. In addition to the major testing
sites, the Center for Molecular Biology and Pathology,
LabCorp's leading-edge esoteric testing facility located in
Research Triangle Park, North Carolina, develops
applications for polymerase chain reaction (PCR) technology,
a revolutionary technique used to produce some of the most
sensitive diagnostic tests ever developed.  LabCorp's
clients include physicians, state and federal governments,
managed care organizations, hospitals, clinics,
pharmaceutical and many Fortune 1000 companies, and other
clinical laboratories.